Novartis Agreement definition

Novartis Agreement means that certain Research Collaboration and License Agreement between Novartis Institutes for BioMedical Research, Inc. (“Novartis”) and ALNYLAM dated October 12, 2005, as amended by the Addendum Re: Influenza Program to Research Collaboration and License Agreement effective as of February 17, 2006, and as further amended from time to time.

Novartis Agreement means the Manufacturing and Supply Agreement, effective as of January 1, 2019, by and between Novartis Pharma AG and Societal CDMO Gainesville LLC (f/k/a Recro Gainesville LLC), as amended, restated, amended and restated, supplemented or otherwise modified from time to time.

Novartis Agreement means the Research Collaboration and License Agreement, effective as of October 12, 2005, by and between Alnylam and Novartis, as amended by the Addendum Re: Influenza Program effective as of December 13, 2005, Amendment No. 1 to such Addendum effective as of March 14, 2006, and Amendment No. 2 to such Addendum effective as of May 5, 2006, and as the same may be amended from time to time after the Execution Date in accordance with Section 2.7(c).

Examples of Novartis Agreement in a sentence

• As of January 2020, there were no Options remaining for purchase and exercise, and accordingly, the Company’s performance obligations under the Novartis Agreement ended.

• Most of the company's revenues derive from the Novartis Agreement, for which revenues consist of reimbursable research and development costs.

• Such assistance and actions will include compliance with the terms of any Pharmacovigilance Agreement entered into by and between CLIENT and Novartis (a copy of which shall be provided by CLIENT to VCS) to the extent that the terms of such agreement supersede the applicable terms of the Novartis Agreement.

• The Parties acknowledge that the selection of each PROTIVA Development Target (other than the Second Target) is subject to Novartis’ right of first offer under the Novartis Agreement and to other binding ALNYLAM obligations to Third Parties pre-existing the date of PROTIVA’s notice to ALNYLAM of PROTIVA’s selection of such Target.

• Under this agreement, or the Novartis Agreement, the Company granted Novartis a co-exclusive license to develop such products worldwide, an exclusive license to commercialize such products outside the United States and a non-exclusive license to support the Company in commercializing such products in the United States if it requests such support.

More Definitions of Novartis Agreement

Novartis Agreement means that certain Promotion Agreement dated as of November 16, 2000 between Novartis Pharmaceuticals Corporation and Reliant Pharmaceuticals, LLC, as amended.

Novartis Agreement means that certain License and Supply Agreement dated March 3, 2008 by and between CLIENT and Novartis, as same may be amended from time to time.

Novartis Agreement means the Asset Purchase Agreement, dated as of December 13, 2022, among the Company, Novartis Technology, LLC and Novartis Innovative Therapies AG, as the same may be amended, restated, supplemented or otherwise modified from time to time.

Novartis Agreement means the Everolimus Local Delivery License Agreement (Exclusive), dated September 17, 2002, by and between Novartis Pharma AG and Novartis AG, both Swiss corporations, and Advanced Cardiovascular Systems, Inc., a California corporation, on behalf of itself and its affiliates, as amended and/or supplemented from time to time.

Novartis Agreement means the agreement between Novartis Pharma AG and Midatech Limited dated as of 5 June, 2017 which relates to the Product codenamed "MTX 110" (as described in Exhibit B), a copy of which is set outhttps://sxxxxxx.xxxxxxxxxxxx.xxx/#xxxxxxxxxx;.

Novartis Agreement means that certain License Agreement by and between Novartis Pharma AG and Axxxx Nortye BioPharma Co. Ltd. dated as of December 22, 2017, together with all ancillary agreements referenced therein.

Novartis Agreement means that certain agreement between Isis and Ciba-Geigy Limited (now Novartis AG) effective June 3, 1996, and all amendments thereto.